Description

Etamzilat (Etamsylate) Ampoules 12.5% 2 ml. №10

Ingredients

Etamzilat (Etamsylate) 12.5% solution

Mechanism of Action

Etamzilat works by enhancing platelet adhesion and aggregation, promoting hemostasis, and reducing bleeding. It also helps stabilize capillary permeability, which is beneficial in conditions associated with increased vascular fragility.

Pharmacological Properties

Etamzilat (Etamsylate) is a hemostatic agent that acts by increasing platelet activity and reducing bleeding time.

Indications for Use

Etamzilat is indicated for the treatment of acute bleeding episodes in patients with various conditions such as menorrhagia, peptic ulcers, and postoperative bleeding.

Contraindications

Avoid using Etamzilat in patients with a known hypersensitivity to the drug or in those with a history of thromboembolic events.

Side Effects

Common side effects of Etamzilat may include nausea, vomiting, and allergic reactions. Consult a healthcare provider for a complete list of side effects.

Usage Instructions

The usual dosage of Etamzilat is 1-2 ampoules per day, administered intramuscularly or intravenously as directed by a healthcare provider.

Benefits Compared to Analogues

Compared to other hemostatic agents, Etamzilat has shown comparable efficacy with a favorable safety profile. Its rapid onset of action and ease of administration make it a preferred choice in the management of acute bleeding episodes.

Suitable Patient Groups

Etamzilat is suitable for use in adults, including the elderly population, under proper medical supervision.

Storage and Shelf Life

Store Etamzilat in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product after the specified shelf life.

Packaging Description

Each box of Etamzilat contains 10 ampoules of 2 ml 12.5% solution for intramuscular or intravenous administration.

Clinical Evidence and Proven Effectiveness

Etamzilat (Etamsylate) has been shown to effectively reduce bleeding episodes in various clinical studies. One study published in the Journal of Hematology demonstrated the efficacy of etamsylate in controlling menorrhagia in women of reproductive age. Another study in the Journal of Gastroenterology highlighted its effectiveness in managing bleeding peptic ulcers.